menu
    • menu

    Company profile for Astria Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Astria Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutic treatments for rare diseases, while also developing other product candidates for the treatment of serious lipid disorders.We listen to the voices of HAE patient communities to better understand their unmet needs, which guide all that we do.With patients as our...
    Astria Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapeutic treatments for rare diseases, while also developing other product candidates for the treatment of serious lipid disorders.We listen to the voices of HAE patient communities to better understand their unmet needs, which guide all that we do.With patients as our guiding stars, Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Astria TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 High Street, 28th Floor, Boston, MA 02110
    Telephone
    Telephone
    617-349-1971
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://astriatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/astria-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AstriaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astria Therapeutics Unveils Q3 2025 Financials & Corporate Update
    Astria Therapeutics Unveils Q3 2025 Financials & Corporate Update

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112064626/en/Astria-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Astria Therapeutics Announces Positive Navenibart Data for HAE
    Astria Therapeutics Announces Positive Navenibart Data for HAE

    06 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251106100618/en/Astria-Therapeutics-Announces-Final-Positive-Results-from-All-Enrolled-HAE-Patients-in-the-ALPHA-STAR-Phase-1b2-Trial-of-Navenibart

    BUSINESS WIRE
    06 Nov 2025
    Share Share
    Astria Therapeutics To Present at ACAAI Meeting
    Astria Therapeutics To Present at ACAAI Meeting

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031805612/en/Astria-Therapeutics-to-Present-at-Upcoming-American-College-of-Allergy-Asthma-and-Immunology-Annual-Scientific-Meeting

    BUSINESSWIRE
    31 Oct 2025
    Share Share
    Biocryst Expands Rare Diseases Focus In $700M Astria Deal
    Biocryst Expands Rare Diseases Focus In $700M Astria Deal

    14 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/biocryst-inks-700m-astria-buyout-challenge-takeda-rare-disease-market

    FIERCE BIOTECH
    14 Oct 2025
    Share Share
    Astria Therapeutics To Present At CSACI 80Th Anniversary
    Astria Therapeutics To Present At CSACI 80Th Anniversary

    09 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251009489408/en/Astria-Therapeutics-to-Present-at-Upcoming-CSACI-80th-Anniversary-Scientific-Meeting

    BUSINESSWIRE
    09 Oct 2025
    Share Share
    Astria Pharma Launches Navenibart Trial For Hereditary Angioedema
    Astria Pharma Launches Navenibart Trial For Hereditary Angioedema

    08 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-08/astria-therapeutics-initiates-the-phase-3-orbit-expanse-long-term-trial-of-navenibart-in-people-with

    PHARMIWEB
    08 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search